Article info

Download PDFPDF
Original research
Clinical efficacy and tolerability of 1.5 g/day oral amoxicillin therapy without probenecid for the treatment of syphilis

Authors

  1. Correspondence to Dr Kazuaki Fukushima, Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku 113-8677, Japan; fukushima-ngi{at}umin.ac.jp
View Full Text

Citation

Ikeuchi K, Fukushima K, Tanaka M, et al
Clinical efficacy and tolerability of 1.5 g/day oral amoxicillin therapy without probenecid for the treatment of syphilis

Publication history

  • Received October 6, 2020
  • Revised March 8, 2021
  • Accepted March 12, 2021
  • First published March 29, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.